Comparison of 12-W versus 14-W endovenous laser ablation in the treatment of great saphenous varicose veins: 5-year outcomes from a randomized controlled trial

Vascular and Endovascular Surgery

Volumn 47, Issue 5, 2013, Pages 346-352

  Samuel, Nehemiah ^a   Wallace, Tom ^a   Carradice, Daniel ^a   Mazari, Fayyaz Ak ^a   Chetter, Ian C ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

endovenous laser ablation; laser energy; quality of life; varicose veins; venous clinical severity score

Indexed keywords

ABERDEEN VARICOSE VEIN QUESTIONNAIRE; ADULT; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOVENOUS LASER ABLATION; FEMALE; FEMORAL VEIN; FOLLOW UP; FUNCTIONAL ASSESSMENT; GREAT SAPHENOUS VEIN VARICOSIS; HUMAN; LEG VARICOSIS; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SAPHENOFEMORAL JUNCTION; SAPHENOUS VEIN; SCORING SYSTEM; SHORT FORM 36; TREATMENT DURATION; TREATMENT OUTCOME; VEIN INSUFFICIENCY; VENOUS CLINICAL SEVERITY SCORE;

EID: 84880730061     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574413487265     Document Type: Article

References (34)

1. Min RJ, Khilnani N, Zimmet SE. Endovenous laser treatment of saphenous vein reflux: long-term results. J Vasc Interv Radiol. 2003 ; 14 (8). 991-996
2. van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg. 2009 ; 49 (1). 230-239
3. Luebke T, Brunkwall J. Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. J Cardiovasc Surg. 2008 ; 49 (2). 213-233
4. Van Den Bos RR, Neumann M, De Roos KP, Nijsten T. Endovenous laser ablation-induced complications: review of the literature and new cases. Dermatol Surg. 2009 ; 35 (8). 1206-1214
5. Leopardi D, Hoggan BL, Fitridge RA, Woodruff PW, Maddern GJ. Systematic review of treatments for varicose veins. Ann Vasc Surg. 2009 ; 23 (2). 264-276
6. Mundy L, Merlin TL, Fitridge RA, Hiller JE. Systematic review of endovenous laser treatment for varicose veins. Br J Surg. 2005 ; 92 (10). 1189-1194
7. Garratt AM, Macdonald LM, Ruta DA, Russell IT, Buckingham JK, Krukowski ZH. Towards measurement of outcome for patients with varicose veins. Qual Health Care. 1993 ; 2 (1). 5-10
8. Smith JJ, Garratt AM, Guest M, Greenhalgh RM, Davies AH. Evaluating and improving health-related quality of life in patients with varicose veins. J Vasc Surg. 1999 ; 30 (4). 710-719
9. Garratt AM, Ruta DA, Abdalla MI, Russell IT. Responsiveness of the SF-36 and a condition-specific measure of health for patients with varicose veins. Qual Life Res. 1996 ; 5 (2). 223-234
10. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004 ; 40 (6). 1248-1252
11. Beebe HG, Bergan JJ, Bergqvist D, et al. Classification and grading of chronic venous disease in the lower limbs. A consensus statement. Eur J Vasc Endovasc Surg. 1996 ; 12 (4). 487-491
12. Kakkos SK, Rivera MA, Matsagas MI, et al. Validation of the new venous severity scoring system in varicose vein surgery. J Vasc Surg. 2003 ; 38 (2). 224-228
13. Rutherford RB, Padberg FT, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000 ; 31 (6). 1307-1312
14. Meissner MH, Natiello C, Nicholls SC. Performance characteristics of the venous clinical severity score. J Vasc Surg. 2002 ; 36 (5). 889-895
15. Garratt AM, Ruta DA, Abdalla MI, Russell IT. SF 36 health survey questionnaire: II. Responsiveness to changes in health status in four common clinical conditions. Qual Health Care. 1994 ; 3 (4). 186-192
16. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002 ; 21 (2). 271-292
17. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ. 1996 ; 5 (2). 141-154
18. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993 ; 2 (3). 169-180
19. Brooks R. EuroQol: the current state of play. Health Policy. 1996 ; 37 (1). 53-72
20. The EuroQol Group. Health Policy. 1990 ; 16 (3). 199-208
21. Michaels JA, Campbell WB, Brazier JE, et al. Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). Health Technol Assess. 2006 ; 10 (13). 1 iii - 196 iv
22. Weiss RA. Comparison of endovenous radiofrequency versus 810 nm diode laser occlusion of large veins in an animal model. Dermatol Surg. 2002 ; 28 (1). 56-61
23. Bush RG, Shamma HN. Hammond KA. 940-nm laser for treatment of saphenous insufficiency: histological analysis and long-term follow-up. Photomed Laser Surg. 2005 ; 23 (1). 15-19
24. Theivacumar NS, Dellagrammaticas D, Beale RJ, Mavor AI, Gough MJ. Factors influencing the effectiveness of endovenous laser ablation (EVLA) in the treatment of great saphenous vein reflux. Eur J Vasc Endovasc Surg. 2008 ; 35 (1). 119-123
25. Proebstle TM, Krummenauer F, Gul D, Knop J. Nonocclusion and early reopening of the great saphenous vein after endovenous laser treatment is fluence dependent. Dermatol Surg. 2004 ; 30 (2 pt 1). 174-178
26. Timperman PE, Sichlau M, Ryu RK. Greater energy delivery improves treatment success of endovenous laser treatment of incompetent saphenous veins. J Vasc Interv Radiol. 2004 ; 15 (10). 1061-1063
27. De Felice E. Shedding light: laser physics and mechanism of action. Phlebology. 2010 ; 25 (1). 11-28
28. Proebstle TM, Moehler T, Herdemann S. Reduced recanalization rates of the great saphenous vein after endovenous laser treatment with increased energy dosing: definition of a threshold for the endovenous fluence equivalent. J Vasc Surg. 2006 ; 44 (4). 834-839
29. Timperman PE. Prospective evaluation of higher energy great saphenous vein endovenous laser treatment. J Vasc Interv Radiol. 2005 ; 16 (6). 791-794
30. Perkowski P, Ravi R, Gowda RC, et al. Endovenous laser ablation of the saphenous vein for treatment of venous insufficiency and varicose veins: early results from a large single-center experience. J Endovasc Ther. 2004 ; 11 (2). 132-138
31. Theivacumar NS, Dellagrammaticas D, Darwood RJ, Mavor AI, Gough MJ. Fate of the great saphenous vein following endovenous laser ablation: does re-canalisation mean recurrence?. Eur J Vasc Endovasc Surg. 2008 ; 36 (2). 211-215
32. Theivacumar NS, Dellagrammaticas D, Beale RJ, Mavor AI, Gough MJ. Fate and clinical significance of saphenofemoral junction tributaries following endovenous laser ablation of great saphenous vein. Br J Surg. 2007 ; 94 (6). 722-725
33. Theivacumar NS, Darwood R, Gough MJ. Neovascularisation and recurrence 2 years after varicose vein treatment for sapheno-femoral and great saphenous vein reflux: a comparison of surgery and endovenous laser ablation. Eur J Vasc Endovasc Surg. 2009 ; 38 (2). 203-207
34. Disselhoff BC, der Kinderen DJ, Kelder JC, Moll FL. Five-year results of a randomised clinical trial of endovenous laser ablation of the great saphenous vein with and without ligation of the saphenofemoral junction. Eur J Vasc Endovasc Surg. 2011 ; 41 (5). 685-690